These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32424556)

  • 41. [Rare diseases in dentistry and oral medicine : Report on the 2017 first national congress].
    Hanisch M; Jung S; Kleinheinz J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Apr; 61(4):442-445. PubMed ID: 29445842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of New National Rare Disease (Nambyo) Registry and Registry Guidelines in Japan.
    Mizushima H; Tanabe M; Sugamori Y; Sato Y; Ogata H
    Stud Health Technol Inform; 2017; 245():536-538. PubMed ID: 29295152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Creating a European registry of patient registries--a service oriented approach].
    Pajić V; Pristas I; Meglic M
    Acta Med Croatica; 2013 Jun; 67(3):233-40. PubMed ID: 25007433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The NIH Office of Rare Diseases Research patient registry Standard: a report from the University of New Mexico's Oculopharyngeal Muscular Dystrophy Patient Registry.
    Daneshvari S; Youssof S; Kroth PJ
    AMIA Annu Symp Proc; 2013; 2013():269-77. PubMed ID: 24551336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
    Steinhagen-Thiessen E; Stroes E; Soran H; Johnson C; Moulin P; Iotti G; Zibellini M; Ossenkoppele B; Dippel M; Averna MR;
    Atherosclerosis; 2017 Jul; 262():146-153. PubMed ID: 28284702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Reliable health information for patients with rare diseases : Quality demands defined by the National Action Plan and how they are put into practice].
    Schaefer C; Brunsmann F; Siegert S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):510-516. PubMed ID: 28289777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rare diseases from a life insurance perspective].
    Senn A; Filzmaier K
    Versicherungsmedizin; 2015 Dec; 67(4):180-3. PubMed ID: 26775306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry.
    Woodward L; Johnson S; Walle JV; Beck J; Gasteyger C; Licht C; Ariceta G;
    Orphanet J Rare Dis; 2016 Nov; 11(1):154. PubMed ID: 27871301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interoperability of population-based patient registries.
    Nicholson N; Perego A
    J Biomed Inform; 2020; 112S():100074. PubMed ID: 34417011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interoperability of population-based patient registries.
    Nicholson N; Perego A
    J Biomed Inform X; 2020 Sep; 6():100074. PubMed ID: 32838295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of Metadata Services for Clinical Data Interoperability in Germany.
    Löbe M; Beyan O; Stäubert S; Meineke F; Ammon D; Winter A; Decker S; Löffler M; Kirsten T
    Stud Health Technol Inform; 2019 Aug; 264():1528-1529. PubMed ID: 31438215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping of Health Care Providers for People with Rare Diseases - From Vision to Implementation.
    Schaefer J; Tegtbauer N; Pfeiffer W; Wagner TOF; Storf H
    Stud Health Technol Inform; 2018; 247():940-944. PubMed ID: 29678099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supporting international networks through platforms for standardised data collection-the European Registries for Rare Endocrine Conditions (EuRRECa) model.
    Ali SR; Bryce J; Smythe C; Hytiris M; Priego AL; Appelman-Dijkstra NM; Ahmed SF
    Endocrine; 2021 Mar; 71(3):555-560. PubMed ID: 33512655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
    Rubinstein YR; Posada de la Paz M; Mora M
    Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Implementing a population-based rare diseases registry in Spain: the Navarre´s experience].
    Vicente E; Guevara M; Lasanta MJ; Ramos-Arroyo MA; Ardanaz E
    Rev Esp Salud Publica; 2018 Nov; 92():. PubMed ID: 30442882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Identification of rare diseases in the oral cavity].
    Hanisch M; Jung S; Kleinheinz J
    Internist (Berl); 2018 Sep; 59(9):972-980. PubMed ID: 29974133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An openEHR based approach to improve the semantic interoperability of clinical data registry.
    Min L; Tian Q; Lu X; An J; Duan H
    BMC Med Inform Decis Mak; 2018 Mar; 18(Suppl 1):15. PubMed ID: 29589572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.